Features Screener Stocks Charts
Sign In Sign Up

Glenmark Pharmaceuticals Ltd. Income Statement

NSE:GLENMARK | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

2-year GLENMARK income statement snapshot

Hover the chart icon for YoY change.

FY 2024 - FY 2025
Item Chart 2024 2025
Revenue 126.53B 133.22B
Cost of Revenue -44.13B -43.53B
Gross Profit 82.40B 89.68B
Sales, General & Admin -62.04B -30.22B
Operating Income 14.53B 18.65B
Profit Before Tax 364.95M 13.99B
Net Income -14.34B 10.47B
Diluted Shares 282.18M 282.21M
Diluted EPS -53.22 37.11

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹). EPS is earnings per share.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025